Our work gets us noticed. UBMD physicians make headlines for raising the bar on clinical care, leading community health initatives and conducting groundbreaking research, among other advancements and accomplishments.
Twenty-three faculty members representing 10 departments have joined the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo during the past few months.
The FDA has approved a drug for patients who are 12 and older with classical Hodgkin lymphoma based on the results of a randomized clinical trial led by a UB researcher.
The annual tradition of honoring exemplary instruction at the Jacobs School of Medicine and Biomedical Sciences took place March 11 with the announcement of the Louis A. and Ruth Siegel Awards for Excellence in Teaching.
This year’s Rare Disease Day event Feb. 27 at the Jacobs School of Medicine and Biomedical Sciences focused on updates in research and diagnostics, and advancements in treatment.
The Jacobs School of Medicine and Biomedical Sciences will mark its 180th anniversary at a Night of Distinction on May 2, recognizing leaders whose vision continues to shape health care in Western New York.
